Barry Quart

Barry Quart

Vorstandsvorsitzender bei CONNECT BIOPHARMA HOLDINGS LIMITED

Vermögen: 836 740 $ am 31.05.2024

67 Jahre
Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Barry Quart

EinheitArt der EinheitIndustrie
Public Company Biotechnology 36
29
Subsidiary Pharmaceuticals: Major 29
Extinct Biotechnology 27
Public Company Pharmaceuticals: Major 27
12
Extinct Pharmaceuticals: Major 12
Public Company Pharmaceuticals: Major 11
5
Subsidiary Pharmaceuticals: Major 5
4
Subsidiary Pharmaceuticals: Major 4
3
Holding Company Pharmaceuticals: Major 3

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Barry Quart

UnternehmenSektorVerknüpfte PersonenHauptposition
Stanford University College/University

Felix Baker

Jean Liu

Gregory H. Turnbull

Thomas Malley

Zuie Chin Huang

Stephen Biggar

E. Lawrence Hill

Doctorate Degree

Graduate Degree

Masters Business Admin

Undergraduate Degree

Graduate Degree

Doctorate Degree

Graduate Degree

Medical Specialties

Peter Wirth

Mark Goldberg

Sanj Patel

Stephen Mahoney

Thomas Beetham

Tracey McCain

General Counsel

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

University of Pennsylvania College/University

Susan Rodriguez

Richard Levy

Kevin Kotler

John Paolini

Tracey McCain

Anita Gupta

Graduate Degree

Doctorate Degree

Undergraduate Degree

Corporate Officer/Principal

Undergraduate Degree

Corporate Officer/Principal

Pharmaceuticals: Major

Jean Liu

Kleanthis Xanthopoulos

Karen Wilson

Wubin Pan

Steven Chan

Kan Chen

Director/Board Member

Director/Board Member

Director/Board Member

Founder

Director of Finance/CFO

Director/Board Member

PFIZER, INC. Pharmaceuticals: Major

Martin Mattingly

John W. Poyhonen

Michael A. Adam

James R. Thomas

John Paolini

Sales & Marketing

Sales & Marketing

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Pharmaceuticals: Major

Martin Mattingly

John W. Poyhonen

Michael A. Adam

Neil James Clendeninn

James R. Thomas

Corporate Officer/Principal

Sales & Marketing

General Counsel

Chief Tech/Sci/R&D Officer

Director of Finance/CFO

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

William T. Comer

Wendy Dixon

Kimberly Manhard

Michael A. Adam

Zuie Chin Huang

Corporate Officer/Principal

Sales & Marketing

General Counsel

General Counsel

Corporate Officer/Principal

GENOMIC HEALTH, INC. Medical Specialties

Felix Baker

Henry Fuchs

Kim Popovits

G. Cole

Director/Board Member

Director/Board Member

Chief Executive Officer

Director of Finance/CFO

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Felix Baker

Carsten Boess

Michael V. Greco

Melissa Manno

Director/Board Member

Director of Finance/CFO

General Counsel

Corporate Officer/Principal

SEAGEN INC. Pharmaceuticals: Major

Felix Baker

Jean Liu

John B. Whelan

Chairman

General Counsel

Corporate Officer/Principal

ODONATE, INC. Pharmaceuticals: Major

Kevin Tang

Craig Johnson

Robert H. Rosen

Chief Executive Officer

Director/Board Member

Director/Board Member

Brown University College/University

Thomas Tisch

Richard Levy

Paul G. Marshall

Corporate Officer/Principal

Undergraduate Degree

Graduate Degree

INCYTE CORPORATION Pharmaceuticals: Major

Thomas Tisch

Wendy Dixon

Richard Levy

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

LA JOLLA PHARMACEUTICAL COMPANY Pharmaceuticals: Major

Kevin Tang

Craig Johnson

Robert H. Rosen

Chairman

Director/Board Member

Director/Board Member

ACADIA PHARMACEUTICALS INC. Pharmaceuticals: Major

Kimberly Manhard

Stephen Davis

Stephen Biggar

Corporate Officer/Principal

Chief Executive Officer

Chairman

University of California, Berkeley College/University

Karen Wilson

Zuie Chin Huang

John B. Whelan

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

College/University

Kevin Tang

David Szekeres

Madelyn Zeylikman

Undergraduate Degree

Graduate Degree

Undergraduate Degree

College/University

Lei Sun

Gregory A. Grabowski

Adam Morgan

Doctorate Degree

Doctorate Degree

Undergraduate Degree

Pharmaceuticals: Major

Mark Goldberg

Kan Chen

Chief Tech/Sci/R&D Officer

Director/Board Member

BLUEBIRD BIO, INC. Biotechnology

Wendy Dixon

Chad Morin

Director/Board Member

Compliance Officer

BLUEPRINT MEDICINES CORPORATION Biotechnology

Mark Goldberg

Tracey McCain

Director/Board Member

Compliance Officer

BIODELIVERY SCIENCES INTERNATIONAL, INC. Pharmaceuticals: Major

Paul Blake

Kevin Kotler

Chief Tech/Sci/R&D Officer

Director/Board Member

Biotechnology

Henry Fuchs

Kim Popovits

Corporate Officer/Principal

Sales & Marketing

Investment Managers

Kevin Kotler

Adam Morgan

Chief Executive Officer

Analyst-Equity

The University of North Carolina at Charlotte College/University

Neil James Clendeninn

Andrew L. Graham

Corporate Officer/Principal

Masters Business Admin

Pharmaceuticals: Major

Paul Goddard

Henry Fuchs

Director/Board Member

Chief Tech/Sci/R&D Officer

MERCK & CO., INC. Pharmaceuticals: Major

Wendy Dixon

John Paolini

Sales & Marketing

Corporate Officer/Principal

MIRATI THERAPEUTICS Biotechnology

Henry Fuchs

Craig Johnson

Director/Board Member

Director/Board Member

ARDELYX, INC. Pharmaceuticals: Major

Susan Rodriguez

Robert Bazemore

Corporate Officer/Principal

Director/Board Member

IMMUNOGEN, INC. Biotechnology

Mark Goldberg

Tracey McCain

Director/Board Member

Director/Board Member

ORGANOVO HOLDINGS, INC. Biotechnology

Christopher Heberlig

Jeffrey Miner

Director of Finance/CFO

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Kleanthis Xanthopoulos

James M. Mackay

Corporate Officer/Principal

Director/Board Member

Biotechnology

Kleanthis Xanthopoulos

Kimberly Manhard

Chief Executive Officer

Director/Board Member

Michigan State University College/University

John W. Poyhonen

Kim Popovits

Undergraduate Degree

Undergraduate Degree

J.E.M. CAPITAL INC Financial Conglomerates

Kleanthis Xanthopoulos

Christopher Krueger

Director/Board Member

Corporate Secretary

Pharmaceuticals: Major

Kleanthis Xanthopoulos

Christopher Krueger

Director/Board Member

Corporate Officer/Principal

ARENA PHARMACEUTICALS Pharmaceuticals: Major

Robert Hoffman

Zheng Wei

Director of Finance/CFO

Corporate Officer/Principal

REGULUS THERAPEUTICS INC. Pharmaceuticals: Major

Kleanthis Xanthopoulos

David Szekeres

Chief Executive Officer

Director of Finance/CFO

Biotechnology

Kleanthis Xanthopoulos

Christopher Krueger

Corporate Officer/Principal

General Counsel

College/University

Robert H. Rosen

Eben Tessari

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Kleanthis Xanthopoulos

Michael A. Adam

Founder

Corporate Officer/Principal

KURA ONCOLOGY, INC. Biotechnology

Thomas Malley

Robert Hoffman

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Robert H. Rosen

John Paolini

Corporate Officer/Principal

Corporate Officer/Principal

Statistik

International

Vereinigte Staaten 48
China 3
Hong Kong 2

Sektoral

Health Technology 38
Consumer Services 10
Commercial Services 3
Finance 3

Operativ

Director/Board Member 377
Corporate Officer/Principal 227
Independent Dir/Board Member 148
Undergraduate Degree 84
Director of Finance/CFO 68
  1. Börse
  2. Insiders
  3. Barry Quart
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT